Study Reports That Harvest Technologies Corporation’s BMAC(TM) Point-Of-Care System For Concentrating Autologous Adult Bone Marrow Stem Cells Gives New Hope To Patients With End-Stage Critical Limb Ischemia Facing Leg Amputation

PLYMOUTH, MA -- (MARKET WIRE) -- December 06, 2006 -- "I believe the Harvest technology may do for regenerative medicine what 'PCR' has done for cloning genes and discovering drugs... It is a 'changing' technology." -- Berthold Amann, MD, Vascular Medicine Specialist, Berlin Vasculature Center.